Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Lily Chu, Ian J. Valencia, Donn W. Garvert and 1 more

Frontiers in Pediatrics · 2019 · CC BY

doi:10.3389/fped.2019.00012

Abstract

Background: Epidemiologic studies of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) have examined different aspects of this disease separately but few have explored them together. Objective: Describe ME/CFS onset and course in one United States-based cohort. Methods: 150 subjects fitting Fukuda 1994 CFS criteria completed a detailed survey concerning the initial and subsequent stages of their illness. Descriptive statistics, graphs, and tables were used to illustrate prevalence and patterns of characteristics. Results: The most common peri-onset events reported by subjects were infection-related episodes (64%), stressful incidents (39%), and exposure to environmental toxins (20%). For 38% of subjects, more than 6 months elapsed from experiencing any initial symptom to developing the set of symptoms comprising their ME/CFS. Over time, the 12 most common symptoms persisted but declined in prevalence, with fatigue, unrefreshing sleep, exertion-related sickness, and flu-like symptoms declining the most (by 20%-25%). Conversely, cognitive symptoms changed the least in prevalence, rising in symptom ranking. Pregnancy, menopause, and menstrual cycles exacerbated many women’s symptoms. Fatigue-related function was not associated with duration of illness or age; during the worst periods of their illness, 48% of subjects could not engage in any productive activity. At the time of survey, 47% were unable to work and only 4% felt their condition was improving steadily with the majority (59%) describing a fluctuating course. Ninety-seven percent suffered from at least one other illness: anxiety (48%), depression (43%), fibromyalgia (39%), irritable bowel syndrome (38%), and migraine headaches (37%) were the most diagnosed conditions. Thirteen percent came from families where at least one other first-degree relative was also afflicted, rising to 27% when chronic fatigue of unclear etiology was included. Conclusions: This paper offers a broad epidemiologic overview of one ME/CFS cohort in the United States. While most of our findings are consistent with prior studies, we highlight underexamined aspects of this condition (e.g. the evolution of symptoms) and propose new interpretations of findings. Studying these aspects can offer insight and solutions to the diagnosis, etiology, pathophysiology, and treatment of this condition.

References 168

  1. 1.

    Johnston S Brenu EW Staines D Marshall-Gradisnik S. The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol. (2013 ) 5:105–10.

    Not in our library10.2147/clep.s39876

  2. 2.

    National Academy of Medicine Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Key Facts. National Academy of Sciences, Engineering, Medicine (2015 ). Available online at: https://www.nap.edu/resource/19012/MECFS_KeyFacts.pdf (Accessed August 20, 2018).

    Not in our library

  3. 3.

    Jason LA Porter N Brown M Anderson V Brown A Hunnell J. CFS: a review of epidemiology and natural history studies. Bull IACFS ME (2009 ) 17:88–106.

    Not in our library

  4. 4.
  5. 5.

    Fukuda K Straus SE Hickie I Sharpe MC Dobbins JG Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. (1994 ) 121:953–9.

    Not in our library10.7326/0003-4819-121-12-199412150-00009

  6. 6.

    Institute of Medicine (U.S.), Institute of Medicine (U.S.), editors. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press (2015 ).

    Not in our library

  7. 7.

    Klimas N Patarca-Montero R Disability and Chronic Fatigue Syndrome: Clinical, Legal, and Patient Perspectives. 1st ed Binghamton, NY: Routledge (1998 ). 124 p.

    Not in our library

  8. 8.

    Pendergrast T Brown A Sunnquist M Jantke R Newton JL Strand EB. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. (2016 ) 12:292–307.

    Not in our library10.1177/1742395316644770

  9. 9.

    Komaroff AL Fagioli LR Doolittle TH Gandek B Gleit MA Guerriero RT. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. (1996 ) 101:281–90.

    Not in our library10.1016/s0002-9343(96)00174-x

  10. 10.
  11. 11.

    Núñez M Núñez E del Val JL Fernández-Huerta JM Alegre C Bonet M Health-related quality of life in chronic fatigue syndrome versus rheumatoid arthritis as control group. J Chronic Fatigue Syndr. (2007 ) 14:31–43.

    Not in our library10.1300/j092v14n02_04

  12. 12.

    Cairns R Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med. (2005 ) 55:20–31.

    Not in our library10.1093/occmed/kqi013

  13. 13.
  14. 14.

    Hickie I Davenport T Wakefield D Vollmer-Conna U Cameron B Vernon SD. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006 ) 333:575.

    Not in our library10.1136/bmj.38933.585764.ae

  15. 15.

    Katz BZ Shiraishi Y Mears CJ Binns HJ Taylor R Chronic fatigue syndrome following infectious mononucleosis in adolescents: a prospective cohort study. Pediatrics (2009 ) 124:189–93.

    Not in our library10.1542/peds.2008-1879

  16. 16.

    Chu L Patient Survey Results for FDA Drug Development Meeting for ME CFS. International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (2013 ). Available online at: http://iacfsme.org/portals/0/pdf/FDA_Survey_Results_Word_Version_July2013%20_2_.pdf (Accessed August 20, 2018).

    Not in our library

  17. 17.

    Barrows DM. Functional capacity evaluations of persons with chronic fatigue immune dysfunction syndrome. Am J Occup Ther. (1995 ) 49:327–37.

    Not in our library10.5014/ajot.49.4.327

  18. 18.

    Friedberg F Dechene L McKenzie MJ Fontanetta R. Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res. (2000 ) 48:59–68.

    Not in our library10.1016/s0022-3999(99)00077-x

  19. 19.

    Jason LA. Natural history of chronic fatigue syndrome. Rehabil Psychol. (2011 ) 56:32–42.

    Not in our library10.1037/a0022595

  20. 20.

    Tiersky LA DeLuca J Hill N Dhar SK Johnson SK Lange G. Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability and employment status in chronic fatigue syndrome. Appl Neuropsychol. (2001 ) 8:41–50.

    Not in our library10.1207/s15324826an0801_6

  21. 21.

    Nisenbaum R Jones JF Unger ER Reyes M Reeves WC. A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003 ) 1:49.

    Not in our library10.1186/1477-7525-1-49

  22. 22.

    Jones DEJ Gray J Frith J Newton JL. Fatigue severity remains stable over time and independently associated with orthostatic symptoms in chronic fatigue syndrome: a longitudinal study. J Intern Med. (2011 ) 269:182–8.

    Not in our library10.1111/j.1365-2796.2010.02306.x

  23. 23.

    Nisenbaum R Jones A Jones J Reeves W. Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome. Ann Epidemiol. (2000 ) 10:458.

    Not in our library10.1016/s1047-2797(00)00119-8

  24. 24.

    March D The natural history of chronic fatigue syndrome: evidence from a multi-site clinical epidemiology study. In: Paper Presented at 11th Biennial International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis Conference. San Francisco, CA (2014 ).

    Not in our library

  25. 25.

    Endicott NA. Chronic Fatigue Syndrome in Psychiatric Patients: Lifetime and premorbid personal history of physical health. Psychosom Med. (1998 ) 60:744.

    Not in our library10.1097/00006842-199811000-00017

  26. 26.

    Dansie EJ Furberg H Afari N Buchwald D Edwards K Goldberg J. Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics (2012 ) 53:44–50.

    Not in our library10.1016/j.psym.2011.04.001

  27. 27.

    Aaron LA Burke MM Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. (2000 ) 160:221–7.

    Not in our library10.1001/archinte.160.2.221

  28. 28.

    Aaron LA Herrell R Ashton S Belcourt M Schmaling K Goldberg J. Comorbid clinical conditions in chronic fatigue. J Gen Intern Med. (2001 ) 16:24–31.

    Not in our library10.1046/j.1525-1497.2001.03419.x

  29. 29.

    Bateman L Darakjy S Klimas N Peterson D Levine SM Allen A Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue (2015 ) 3:1–15.

    Not in our library10.1080/21641846.2014.978109

  30. 30.

    Walsh CM Zainal NZ Middleton SJ Paykel ES. A family history study of chronic fatigue syndrome: Psychiatr Genet. (2001 ) 11:123–8.

    Not in our library10.1097/00041444-200109000-00003

  31. 31.

    Torres-Harding SR Jason LA Turkoglu OD Family medical history of persons with chronic fatigue syndrome. J Chronic Fatigue Syndr. (2004 ) 12:25–35.

    Not in our library10.1300/j092v12n04_03

  32. 32.

    Njoku N Jason L DiPasqaule L Family Illnesses Among People With ME/CFS: Blood vs. Non-Blood Relatives. Invest in ME (2009 ). Available online at: http://www.investinme.org/documents/journals/Journal%20of%20IiME%20Vol%202%20Issue%202.pdf (Accessed August 20, 2018).

    Not in our library

  33. 33.

    Albright F Light K Light A Bateman L Cannon-Albright LA. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. (2011 ) 11:62.

    Not in our library10.1186/1471-2377-11-62

  34. 34.

    Pheby D Saffron L Risk factors for severe ME/CFS. Biol Med. (2009 ) 1:50–74.

    Not in our library

  35. 35.

    Underhill RA O'gorman R Prevalence of chronic fatigue syndrome and chronic fatigue within families of CFS patients. J Chronic Fatigue Syndr. (2006 ) 13:3–13.

    Not in our library10.1300/j092v13n01_02

  36. 36.

    Alegre J Castro-Marrero J Ribases M Alista L Saez N Calvo B Family aggregation studies in CFS. In: Paper presented at 11th Biennial International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Conference. San Francisco, CA (2014 ).

    Not in our library

  37. 37.

    Reyes M Nisenbaum R Hoaglin DC Unger ER Emmons C Randall B. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. (2003 ) 163:1530–6.

    Not in our library10.1001/archinte.163.13.1530

  38. 38.
  39. 39.

    Ruiz E Alegre J García Quintana AM Aliste L Blázquez A Fernández de. [Chronic fatigue syndrome: study of a consecutive series of 824 cases assessed in two specialized units]. Rev Clin Esp. (2011 ) 211:385–90.

    Not in our library10.1016/j.rce.2010.10.007

  40. 40.

    Capelli E Lorusso L Ghitti M Venturini L Cusa C Ricevuti G. Chronic fatigue syndrome: features of a population of patients from northern Italy. Int J Immunopathol Pharmacol. (2015 ) 28:53–9.

    Not in our library10.1177/0394632015572074

  41. 41.

    Clark K Del Fante P Burnet R Cahalan P Briggs N Griffith L Myalgic Encephalopathy/Chronic Fatigue Syndrome Longitudinal Outcomes (2006 ). Available online at: http://sacfs.asn.au/download/me_cfs_pilot_study_report.pdf (Accessed September 7, 2018).

    Not in our library

  42. 42.

    Johnston SC Staines DR Marshall-Gradisnik SM. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin Epidemiol. (2016 ) 8:97–107.

    Not in our library10.2147/clep.s96797

  43. 43.

    Japanese Ministry for Health Welfare and Labor National ME/CFS Patient Survey. International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (2017 ) Available online at: http://iacfsme.org/PDFS/2017JanNewsletter/8-Japan-2014-Patient-Survey.aspx (Accessed September 7, 2018).

    Not in our library

  44. 44.

    Chu L Norris JL Valencia IJ Montoya JG Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria. Fatigue (2017 ) 5:114–28.

    Not in our library10.1080/21641846.2017.1299079

  45. 45.

    Chu L Valencia IJ Garvert DW Montoya JG Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: a patient-centered, cross-sectional survey. PLoS ONE. (2018 ) 13:e0197811

    Not in our library10.1371/journal.pone.0197811

  46. 46.

    Smets EM Garssen B Bonke B De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. (1995 ) 39:315–25.

    Not in our library10.1016/0022-3999(94)00125-o

  47. 47.
  48. 48.

    Krupp LB LaRocca NG Muir-Nash J Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. (1989 ) 46:1121–3.

    Not in our library10.1001/archneur.1989.00520460115022

  49. 49.

    Carruthers BM Jain AK Meirleir KLD Peterson DL Klimas NG Lerner AM Myalgic cncephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr. (2003 ) 11:7–115.

    Not in our library10.1300/j092v11n01_02

  50. 50.
  51. 51.

    Castro-Marrero J Faro M Aliste L Sáez-Francàs N Calvo N Martínez-Martínez A. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: a nationwide population-based cohort study. Psychosomatics (2017 ) 58:533–43.

    Not in our library10.1016/j.psym.2017.04.010

  52. 52.

    Evans MA Jason LA Onset patterns of chronic fatigue syndrome and myalgic encephalomyelitis. Res Chronic Dis. (2018 ) 2:1–30.

    Not in our library

  53. 53.
  54. 54.
  55. 55.

    Evans M Barry M Im Y Brown A Jason LA. An investigation of symptoms predating CFS onset. J Prev Interv Community (2015 ) 43:54–61.

    Not in our library10.1080/10852352.2014.973240

  56. 56.

    Jackson ML Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Clin Sleep Med. (2012 ) 8:719–28.

    Not in our library10.5664/jcsm.2276

  57. 57.

    Woolley J Allen R Wessely S. Alcohol use in chronic fatigue syndrome. J Psychosom Res. (2004 ) 56:203–6.

    Not in our library10.1016/s0022-3999(03)00077-1

  58. 58.

    Low PA Sandroni P Joyner M Shen W-K. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. (2009 ) 20:352–8.

    Not in our library10.1111/j.1540-8167.2008.01407.x

  59. 59.

    National, Alliance on Mental Illness Mental Health Facts in America. National Alliance on Mental Illness. Available online at: https://www.nami.org/NAMI/media/NAMI-Media/Infographics/GeneralMHFacts.pdf (Accessed September 5, 2018).

    Not in our library

  60. 60.

    National Fibromyalgia Association Prevalence. National Fibromyalgia Association (NFA). Available online at: http://www.fmaware.org/about-fibromyalgia/prevalence/ (Accessed September 6, 2018).

    Not in our library

  61. 61.

    Endo Y Shoji T Fukudo S. Epidemiology of irritable bowel syndrome. Ann Gastroenterol. (2015 ) 28:158–9.

    Not in our library

  62. 62.

    Womack JP Jimenez M. Common questions about infectious mononucleosis. AFP (2015 ) 91:372–6.

    Not in our library

  63. 63.

    Burch RC Loder S Loder E Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache (2015 ) 55:21–34.

    Not in our library10.1111/head.12482

  64. 64.

    Hayter SM Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. (2012 ) 11:754–65.

    Not in our library10.1016/j.autrev.2012.02.001

  65. 65.

    The American Academy of Allergy, Asthma & Immunology Allergy Statistics. AAAAI. The American Academy of Allergy, Asthma & Immunology. Available online at: https://www.aaaai.org/about-aaaai/newsroom/allergy-statistics (Accessed September 6, 2018).

    Not in our library

  66. 66.

    Orlander PR Hypothyroidism: Practice Essentials, Background, Pathophysiology. Medscape (2018 ). Available online at: https://emedicine.medscape.com/article/122393-overview#a5 (Accessed Sep 6, 2018).

    Not in our library

  67. 67.

    Shields RW Peripheral Neuropathy. Cleveland Clinic Center for Continuing Medical Education (2010 ). Available online at: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/neurology/peripheral-neuropathy/ (Accessed September 6, 2018).

    Not in our library

  68. 68.

    Steinemann A. National prevalence and effects of multiple chemical sensitivities. J Occup Environ Med. (2018 ) 60:e152–6.

    Not in our library10.1097/jom.0000000000001272

  69. 69.

    American Academy of Sleep Medicine Rising Prevalence of Sleep Apnea in U.S. Threatens Public Health. American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers (2014 ). Available online at: https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/ (Accessed September 6, 2018 Sep 6).

    Not in our library

  70. 70.

    Gauer R Semidey MJ. Diagnosis and treatment of temporomandibular disorders. AFP (2015 ) 91:378–86.

    Not in our library

  71. 71.

    Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res. (1997 ) 31:59–65.

    Not in our library10.1016/s0022-3956(96)00050-7

  72. 72.

    Becker PD McGregor N Meirleir KD Possible triggers and mode of onset of chronic fatigue syndrome. J Chronic Fatigue Syndr. (2002 ) 10:3–18.

    Not in our library10.1300/j092v10n02_02

  73. 73.

    Dobbins JG Natelson B Brassloff I Drastal S Sisto S-A Physical, behavioral, and psychological risk Factors for chronic fatigue syndrome: a central role for stress? J Chronic Fatigue Syndr. (1995 ) 1:43–58.

    Not in our library10.1300/j092v01n02_04

  74. 74.

    Kerr JR Mattey DL. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic Parvovirus B19 infection. Clin Infect Dis. (2008 ) 46:e83–7.

    Not in our library10.1086/533471

  75. 75.

    National Academy of Medicine Beyond Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Redefining an Illness - Report Guide For Clinicians. National Academy Press (2015 ) Available online at: https://www.nap.edu/resource/19012/MECFScliniciansguide.pdf (Accessed August 22, 2018).

    Not in our library

  76. 76.

    National Institutes of Health NIH Intramural Study on Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome. National Institutes of Health (2016 ). Available online at: https://mecfs.ctss.nih.gov/ (cited August 23, 2018).

    Not in our library

  77. 77.

    Montoya J Chu L Research Update on Adult ME/CFS. US Department of Health Human Services (2017 ). Available online at: https://www.hhs.gov/sites/default/files/2017-12-cfsac-meeting-presentation-research-updates-on-adult-mecfs.pdf (Accessed September 7, 2018).

    Not in our library

  78. 78.

    ME Action What is ME? [Internet]. ME Action. [cited 23 August 2018]. Available from: https://www.meaction.net/about/what-is-me/

    Not in our library

  79. 79.

    Mayo Clinic Staff Chronic Fatigue Syndrome - Symptoms Causes. Mayo Clinic (2018 ). Available online at: http://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/symptoms-causes/syc-20360490 (Accessed August 23, 2018).

    Not in our library

  80. 80.

    National, Alliance for ME Ramsay's Definition for ME. National Alliance for ME. Available online at: https://web.archive.org/web/20180623215524/http://www.name-us.org/DefintionsPages/DefRamsay.htm (Accessed August 23, 2018).

    Not in our library

  81. 81.

    White PD Thomas JM Amess J Crawford DH Grover SA Kangro HO. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998 ) 173:475–81.

    Not in our library10.1192/bjp.173.6.475

  82. 82.

    Bavinton J Darbishire L White P PACE Manual for Therapists: Graded Exercise Therapy for CFS/ME. Me-PediaOrg (2018 ). Available online at: https://me-pedia.org/images/8/89/PACE-get-therapist-manual.pdf (Accessed August 24, 2018).

    Not in our library

  83. 83.

    Wilshire C Kindlon T Matthees A McGrath S Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial. Fatigue (2017 ) 5:43–56.

    Not in our library10.1080/21641846.2017.1259724

  84. 84.

    Kindlon T Reporting of Harms Associated With Graded Exercise Therapy Cognitive Behavioral Therapy in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome. International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (2011 ). Available online at: https://iacfsme.org/PDFS/Reporting-of-Harms-Associated-with-GET-and-CBT-in.aspx (Accessed August 24, 2018).

    Not in our library

  85. 85.

    Tomas C Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochem Soc Trans. (2018 ) 46:547–53.

    Not in our library10.1042/bst20170503

  86. 86.

    American Psychological Association Stress Weakens the Immune System. American Psychological Association (2006 ). Available online at: http://www.apa.org/research/action/immune.aspx (Accessed August 24, 2018).

    Not in our library

  87. 87.

    Watt T Oberfoell S Balise R Lunn MR Kar AK Merrihew L. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers. J Med Virol. (2012 ) 84:1967–74.

    Not in our library10.1002/jmv.23411

  88. 88.

    Montoya JG Kogelnik AM Bhangoo M Lunn MR Flamand L Merrihew LE. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol. (2013 ) 85:2101–9.

    Not in our library10.1002/jmv.23713

  89. 89.
  90. 90.

    Lerner AM Ariza ME Williams M Jason L Beqaj S Fitzgerald JT. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS ONE (2012 ) 7:e47891.

    Not in our library10.1371/journal.pone.0047891

  91. 91.

    VanNess JM Stevens SR Bateman L Stiles TL Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Womens Health (2010 ) 19:239–44.

    Not in our library10.1089/jwh.2009.1507

  92. 92.

    Tomas C Newton J Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. (2013 ) 2013:784520.

    Not in our library10.1155/2013/784520

  93. 93.

    VanNess J Davenport T Stevens S Stevens J Snell C Chronotropic incompetence in chronic fatigue syndrome/myalgic encephalomyelitis. Presented at Combined Sections Meeting of the American Physical Therapy Association. Anaheim, CA (2016 ).

    Not in our library

  94. 94.

    Burton AR Rahman K Kadota Y Lloyd A Vollmer-Conna U. Reduced heart rate variability predicts poor sleep quality in a case-control study of chronic fatigue syndrome. Exp Brain Res. (2010 ) 204:71–8.

    Not in our library10.1007/s00221-010-2296-1

  95. 95.

    Vital, Lifestyle How Stress Works: The Anatomy & Physiology of Stress. Vital Lifestyle. Available online at: http://www.vitallifestyle.com.au/how-stress-works/ (Accessed September 1, 2018).

    Not in our library

  96. 96.

    Everly GS Lating JM A Clinical Guide to the Treatment of the Human Stress Response. 3rd ed New York, NY: Springer (2013 ). 485 p.

    Not in our library10.1007/978-1-4614-5538-7

  97. 97.

    Loebel M Grabowski P Heidecke H Bauer S Hanitsch LG Wittke K. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun. (2016 ) 52:32–9.

    Not in our library10.1016/j.bbi.2015.09.013

  98. 98.

    Tanaka S Kuratsune H Hidaka Y Hakariya Y Tatsumi K-I Takano T. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. (2003 ) 12:225–30.

    Not in our library10.3892/ijmm.12.2.225

  99. 99.

    Jason LA Katz BZ Shiraishi Y Mears CJ Im Y Taylor RR. Predictors of post-infectious chronic fatigue syndrome in adolescents. Health Psychol Behav Med. (2014 ) 2:41–51.

    Not in our library10.1080/21642850.2013.869176

  100. 100.

    Holmes GP Kaplan JE Gantz NM Komaroff AL Schonberger LB Straus SE. Chronic fatigue syndrome: a working case definition. Ann Intern Med. (1988 ) 108:387–9.

    Not in our library10.7326/0003-4819-108-3-387

  101. 101.

    ME Association (UK) London Criteria for M.E. – For Website Discussion. ME Association (2011 ). Available online at: https://www.meassociation.org.uk/2011/02/london-criteria-for-m-e/ (Accessed September 2, 2018).

    Not in our library

  102. 102.

    Jason LA Damrongvachiraphan D Hunnell J Bartgis L Brown A Evans M Myalgic encephalomyelitis case definitions. Autom Control Physiol State Funct. (2012 ) 1:1–14.

    Not in our library10.4303/acpsf/k110601

  103. 103.

    Jason LA Brown A Evans M Sunnquist M Newton JL. Contrasting chronic fatigue syndrome versus myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue (2013 ) 1:168–83.

    Not in our library10.1080/21641846.2013.774556

  104. 104.

    Ray C Jeffefues S Weir W Hayes K Simon S Akingbade F Making sense of chronic fatigue syndrome: patients' accounts of onset. Psychol Health (1998 ) 13:99–109.

    Not in our library

  105. 105.

    Racciatti D Vecchiet J Ceccomancini A Ricci F Pizzigallo E. Chronic fatigue syndrome following a toxic exposure. Sci Total Environ. (2001 ) 270:27–31.

    Not in our library10.1016/s0048-9697(00)00777-4

  106. 106.

    Behan PO Chronic fatigue syndrome as a delayed reaction to chronic low-dose organophosphate exposure. J Nutr Environ Med. (1996 ) 6:341–50.

    Not in our library10.3109/13590849609007262

  107. 107.

    Adami H-O Berry SCL Breckenridge CB Smith LL Swenberg JA Trichopoulos D. Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci. (2011 ) 122:223–34.

    Not in our library10.1093/toxsci/kfr113

  108. 108.

    Berne K Running on Empty: The Complete Guide to Chronic Fatigue Syndrome. Revised ed. Alameda, CA: Hunter House (1995 ). 315 p.

    Not in our library

  109. 109.

    De Becker P McGregor N De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Intern Med. (2001 ) 250:234–40.

    Not in our library10.1046/j.1365-2796.2001.00890.x

  110. 110.

    Bansal AS. Investigating unexplained fatigue in general practice with a particular focus on CFS/ME. BMC Fam Pract. (2016 ) 17:81.

    Not in our library10.1186/s12875-016-0493-0

  111. 111.

    Lapp C Black L Smith R Symptoms Predict the Outcome of Tilt Table Testing in CFS/ME/FM. Hunter-Hopkins Center. Available online at: http://drlapp.com/wp-content/uploads/TTT_symptoms.pdf (Accessed September 1, 2018).

    Not in our library

  112. 112.

    Rowe PC Lucas KE. Orthostatic intolerance in chronic fatigue syndrome. Am J Med. (2007 ) 120:e13.

    Not in our library10.1016/j.amjmed.2006.02.033

  113. 113.

    Robinson LJ Durham J MacLachlan LL Newton JL Autonomic function in chronic fatigue syndrome with and without painful temporomandibular disorder. Fatigue (2015 ) 3:205–19.

    Not in our library10.1080/21641846.2015.1091152

  114. 114.

    Tansey EA Roe SM Johnson CD. The sympathetic release test: a test used to assess thermoregulation and autonomic control of blood flow. Adv Physiol Educ. (2014 ) 38:87–92.

    Not in our library10.1152/advan.00095.2013

  115. 115.

    Narkiewicz K Cooley RL Somers VK. Alcohol potentiates orthostatic hypotension: implications for alcohol-related syncope. Circulation (2000 ) 101:398–402.

    Not in our library10.1161/01.cir.101.4.398

  116. 116.

    Hornig M Montoya JG Klimas NG Levine S Felsenstein D Bateman L. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. (2015 ) 1:e1400121.

    Not in our library10.1126/sciadv.1400121

  117. 117.

    Costigan A Elliott C McDonald C Newton JL. Orthostatic symptoms predict functional capacity in chronic fatigue syndrome: implications for management. QJM (2010 ) 103:589–95.

    Not in our library10.1093/qjmed/hcq094

  118. 118.

    Deftereos SN Vernon SD Persidis A Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey. Fatigue (2016 ) 4:39–51.

    Not in our library10.1080/21641846.2015.1126025

  119. 119.

    International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis: Primer for Clinical Practitioners. International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (2014 ). Available online at: https://iacfsme.org/portals/0/pdf/Primer_Post_2014_conference.pdf (Accessed September 3, 2018).

    Not in our library

  120. 120.

    X E Why I Believe I Got Sick Again After Making a Full Recovery From ME/CFS. Consciously Healthy (2016 ). Available online at: http://consciouslyhealthy.co.uk/thelessonslearned/ (Accessed September 3, 2018).

    Not in our library

  121. 121.

    Nooram57 Cfs Relapse After 16 Years? Anyone Else?. Reddit/Cfs (2017 ). Available online at: https://www.reddit.com/r/cfs/comments/5a7hol/cfs_relapse_after_16_years_anyone_else/ (Accessed September 7, 2018).

    Not in our library

  122. 122.

    Adamowicz JL Caikauskaite I Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual Life Res. (2014 ) 23:2407–16.

    Not in our library10.1007/s11136-014-0705-9

  123. 123.

    Devendorf AR Jackson CT Sunnquist M Jason LA Defining and measuring recovery from myalgic encephalomyelitis and chronic fatigue syndrome: the physician perspective. Disabil Rehabil. (2017 ) 39:1–8.

    Not in our library10.1080/09638288.2017.1383518

  124. 124.

    Jason LA Richman JA Rademaker AW Jordan KM Plioplys AV Taylor RR. A community-based study of chronic fatigue syndrome. Arch Intern Med. (1999 ) 159:2129–37.

    Not in our library10.1001/archinte.159.18.2129

  125. 125.

    Kidd E Brown A McManimen S Jason L Newton J Strand E. The relationship between age and illness duration in chronic fatigue syndrome. Diagnostics (2016 ) 6:16.

    Not in our library10.3390/diagnostics6020016

  126. 126.

    Gimeno Pi I Guitard Sein-Echaluce ML Rosselló Aubach L Torres Puig-Gros J Fernández Solà J. Stressful events in the onset of chronic fatigue syndrome. Rev Esp Salud Publica. (2016 ) 90:e1–7.

    Not in our library

  127. 127.

    Schacterle RS Komaroff AL. A comparison of pregnancies that occur before and after the onset of chronic fatigue syndrome. Arch Intern Med. (2004 ) 164:401–4.

    Not in our library10.1001/archinte.164.4.401

  128. 128.

    Allen PR. Chronic fatigue syndrome: implications for women and their health care providers during the childbearing years. J Midwifery Womens Health (2008 ) 53:289–301.

    Not in our library10.1016/j.jmwh.2007.12.001

  129. 129.

    Unger ER Lin JMS Brimmer DJ Lapp CW Komaroff AL Nath A. CDC grand rounds: chronic fatigue syndrome — advancing research and clinical education. MMWR (2016 ) 65:1434–8.

    Not in our library10.15585/mmwr.mm655051a4

  130. 130.

    Tavakolpour S Rahimzadeh G New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy. Scand J Immunol. (2016 ) 84:146–9.

    Not in our library10.1111/sji.12453

  131. 131.
  132. 132.

    Studd J Panay N. Chronic fatigue syndrome. Lancet (1996 ) 348:1384.

    Not in our library10.1016/s0140-6736(05)65448-7

  133. 133.

    Kingdon CC Bowman EW Curran H Nacul L Lacerda EM. Functional status and well-being in people with myalgic encephalomyelitis/chronic fatigue syndrome compared with people with multiple sclerosis and healthy controls. Pharmacoecon Open (2018 ) 2:381–92.

    Not in our library10.1007/s41669-018-0071-6

  134. 134.

    Pepper CM Krupp LB Friedberg F Doscher C Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci. (1993 ) 5:200–5.

    Not in our library10.1176/jnp.5.2.200

  135. 135.

    Wise S Jantke R Brown A Jason LA. Functional level of patients with chronic fatigue syndrome reporting use of alternative vs. traditional treatments. Fatigue (2015 ) 3:235–40.

    Not in our library10.1080/21641846.2015.1097102

  136. 136.

    Unger ER Lin J-MS Tian H Natelson BH Lange G Vu D. Multi-Site Clinical Assessment of Myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol. (2017 ) 185:617–26.

    Not in our library10.1093/aje/kwx029

  137. 137.

    Thombs BD Bassel M McGuire L Smith MT Hudson M Haythornthwaite JA. A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology (2008 ) 47:1559–63.

    Not in our library10.1093/rheumatology/ken331

  138. 138.

    Hedlund L Gyllensten AL Hansson L. A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders. Community Mental Health J. (2015 ) 51:377–82.

    Not in our library10.1007/s10597-014-9746-3

  139. 139.

    Valko PO Bassetti CL Bloch KE Held U Baumann CR. Validation of the Fatigue Severity Scale in a Swiss cohort. Sleep (2008 ) 31:1601–7.

    Not in our library10.1093/sleep/31.11.1601

  140. 140.

    Johansson S Kottorp A Lee KA Gay CL Lerdal A. Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach. Health Qual Life Outcomes (2014 ) 12:24.

    Not in our library10.1186/1477-7525-12-24

  141. 141.

    Chu L Post-exertional malaise symptoms and abnormal cardiopulmonary exercise testing are associated with decreased physical functioning in myalgic encephalomyelitis/ chronic fatigue syndrome. In:Poster Presented at 11th Biennial International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis Conference. San Francisco, CA (2014 ).

    Not in our library

  142. 142.

    Matthews RM Komaroff AL Changes in functional status in chronic fatigue syndrome over a decade: do age and gender matter? J Chronic Fatigue Syndr. (2007 ) 14:33–42.

    Not in our library10.1300/j092v14n01_04

  143. 143.

    Lewis I Pairman J Spickett G Newton JL. Is Chronic fatigue syndrome in older patients a different disease? - a clinical cohort study. Eur J Clin Investig. (2013 ) 43:302–8.

    Not in our library10.1111/eci.12046

  144. 144.
  145. 145.

    US Cancer Statistics United States Cancer Statistics: Data Visualizations. Centers for Disease Control Prevention (2015 ). Available online at: https://gis.cdc.gov/grasp/USCS/DataViz.html (Accessed September 6, 2018).

    Not in our library

  146. 146.

    Chang CM Warren JL Engels EA Chronic fatigue syndrome and subsequent risk of cancer among elderly U.S. adults. Cancer (2012 ) 118:5929–36.

    Not in our library10.1002/cncr.27612

  147. 147.

    McManimen SL Devendorf AR Brown AA Moore BC Moore JH Jason LA. Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome. Fatigue (2016 ) 4:195–207.

    Not in our library10.1080/21641846.2016.1236588

  148. 148.

    Jason LA Sunnquist M Kot B Brown A Unintended consequences of not specifying exclusionary illnesses for Systemic Exertion Intolerance Disease. Diagnostics (2015 ) 5:272–86.

    Not in our library10.3390/diagnostics5020272

  149. 149.

    McKeon JMM McKeon PO A balancing act between control and generalizability. Int J Athletic Ther Training (2016 ) 21:1–3.

    Not in our library10.1123/ijatt.2016-0010

  150. 150.

    Millar E Dowell T Lawrenson R Mangin D Sarfati D. Clinical guidelines: what happens when people have multiple conditions? N Z Med J. (2018 ) 131:73–81.

    Not in our library

  151. 151.

    Burstein R Noseda R Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. (2015 ) 35:6619–29.

    Not in our library10.1523/jneurosci.0373-15.2015

  152. 152.

    Solomon L Reeves WC. Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med. (2004 ) 164:2241.

    Not in our library10.1001/archinte.164.20.2241

  153. 153.

    Jason LA Taylor RR Kennedy CL Song S Johnson D Torres S. Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community-based sample: J Nerv Ment Dis. (2000 ) 188:568–76.

    Not in our library10.1097/00005053-200009000-00002

  154. 154.

    Palacios N Fitzgerald KC Komaroff AL Ascherio A Incidence of myalgic encephalomyelitis/chronic fatigue syndrome in a large prospective cohort of U.S. nurses. Fatigue (2017 ) 5:159–66.

    Not in our library10.1080/21641846.2017.1323576

  155. 155.

    Endicott NA. Chronic fatigue syndrome in private practice psychiatry: family history of physical and mental health. J Psychosom Res. (1999 ) 47:343–54.

    Not in our library10.1016/s0022-3999(99)00013-6

  156. 156.

    Levine PH Whiteside TL Friberg D Bryant J Colclough G Herberman RB. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol. (1998 ) 88:96–104.

    Not in our library10.1006/clin.1998.4554

  157. 157.

    Blomberg J Gottfries C-G Elfaitouri A Rizwan M Rosén A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. (2018 ) 9:299.

    Not in our library10.3389/fimmu.2018.00229

  158. 158.

    Sotzny F Blanco J Capelli E Castro-Marrero J Steiner S Murovska M. Myalgic encephalomyelitis/chronic fatigue syndrome – evidence for an autoimmune disease. Autoimmun Rev. (2018 ) 17:601–9.

    Not in our library10.1016/j.autrev.2018.01.009

  159. 159.

    Berkovich R Staying Ahead of Multiple Autoimmune Disorders. Healio Rheumatology (2016 ). Available online at: https://www.healio.com/rheumatology/rheumatoid-arthritis/news/print/healio-rheumatology/%7bed6a292b-402b-402b-82ca-c2c2e9c01e3b%7d/staying-ahead-of-multiple-autoimmune-disorders (Accessed September 7, 2018).

    Not in our library

  160. 160.
  161. 161.

    Rose NR Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today (1993 ) 14:426–30.

    Not in our library10.1016/0167-5699(93)90244-f

  162. 162.

    Mackay IR Rose NR The Autoimmune Diseases. Cambridge, MA: Elsevier (2006 ). 1161 p.

    Not in our library

  163. 163.

    Fluge Ø Mella O Bruland O Risa K Dyrstad SE Alme K. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight (2016 ) 1:e89376.

    Not in our library10.1172/jci.insight.89376

  164. 164.

    Sunnquist M Jason LA Brown A Evans M Berman A. Complications in operationalizing lifelong fatigue as an exclusionary criterion. J Prev Interv Community (2015 ) 43:42–53.

    Not in our library10.1080/10852352.2014.973238

  165. 165.

    Jones JF Nisenbaum R Reeves WC. Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas. Health Qual Life Outcomes (2003 ) 1:74.

    Not in our library10.1186/1477-7525-1-74

  166. 166.

    Gotts ZM Deary V Newton J Dussen DV der Roy PD Ellis JG. Are there sleep-specific phenotypes in patients with chronic fatigue syndrome? A cross-sectional polysomnography analysis. BMJ Open (2013 ) 3:e002999.

    Not in our library10.1136/bmjopen-2013-002999

  167. 167.

    US National Institutes of Health Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54). US National Institutes of Health (2017 ). Available online at: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-17-021.html (Accessed September 10, 2018).

    Not in our library

  168. 168.

    Evans M Jason LA. Effects of time frame on the recall reliability of CFS symptoms. Eval Health Profess. (2015 ) 38:367–81.

    Not in our library10.1177/0163278713497014

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.